CERO - CERO THERAPEUTICS HOLDINGS, INC.

0.0951
-1.695   -1,782.229%

Share volume: 45,096,838
Last Updated: 10-30-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.19%

PREVIOUS CLOSE
CHG
CHG%
$1.79
-1.69
-0.95%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 43%
Liquidity 23%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
-97.97%
1 Year
-93.53%
2 Year
-96.91%
Key data
Stock price
$0.10
P/E Ratio 
0.00
DAY RANGE
$0.08 - $0.40
EPS 
-$10.93
52 WEEK RANGE
$0.08 - $26.99
52 WEEK CHANGE
-$93.30
MARKET CAP 
155.000 M
YIELD 
N/A
SHARES OUTSTANDING 
21.103 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
01-08-2025
NEXT EARNINGS DATE
N/A
BETA 
-4.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Christopher B. Ehrlich
Region: US
Website: N/A
Employees: 0
IPO year: 2025
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe.

Recent news